“We are extremely pleased to have Chris join INC Research,” said Chief Executive Officer James Ogle. “Chris brings a wealth of experience and a solid understanding of the regulatory and legal issues affecting the Company and the pharmaceutical industry, and will be a valuable addition to our executive team.”
Prior to joining INC Research, Gaenzle was assistant general counsel at Pfizer Inc. His experience also includes serving as a partner at Hunton and Williams.
Gaenzle received his undergraduate degree from Colgate University and earned his JD from Syracuse University. He was also a visiting student at Washington & Lee University School of Law. Gaenzle is admitted to the bar in New York and Virginia.
About INC Research
INC Research is a therapeutically focused clinical research organization with a high-performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in all therapeutic areas and innovative pediatric and women's health trials. The Company's Trusted Process® methodology and therapeutic foresight lead customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information, please visit www.incresearch.com or follow us at @inc_research.
